Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Total Current Liabilities (2009 - 2026)

Evotec SE's (EVO) quarterly Total Current Liabilities came in at $363.2 million in Q2 2026, down 16.27% year-over-year from $433.7 million in Q2 2025, and down 26.73% quarter-over-quarter from $495.7 million in Q1 2026.

Analysis

Evotec SE (EVO) Total Current Liabilities (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Total Current Liabilities across 9 years of filings, most recently posting $363.2 million for Q2 2026.

  • In Q2 2026, Total Current Liabilities fell 16.27% year-over-year to $363.2 million; the TTM figure through Jun 2026 stood at $363.2 million (down 16.27% YoY), while the FY2025 annual figure was $415.9 million, up 11.5% from the prior year.
  • Total Current Liabilities came in at $363.2 million for Q2 2026 at Evotec SE, down from $495.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $531.5 million in Q2 2023 to a low of $343.6 million in Q3 2022.
  • Average Total Current Liabilities over 5 years is $413.0 million, with a median of $381.2 million recorded in 2022.
  • Year-over-year, Total Current Liabilities surged 45.08% in 2023 and declined 26.33% in 2024.
  • Over 5 years, Total Current Liabilities stood at $344.5 million in 2022, then surged by 45.08% to $499.9 million in 2023, then dropped by 26.33% to $368.2 million in 2024, then gained by 16.36% to $428.5 million in 2025, then decreased by 15.23% to $363.2 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $363.2 million in Q2 2026, $495.7 million in Q1 2026, and $428.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn 8.82 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 1.44 Bn
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn 1.13 Bn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn 3.93 Bn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn 963.70 Mn
6 Evotec SE 642.83 Mn 216.96 Mn - 363.19 Mn
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn 72.74 Mn
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn 19.92 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn 4.22 Mn
10 VivoSim Labs 1.45 Mn 1.45 Mn - 1.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 363.19 Mn
Mar 31, 2026 495.66 Mn
Dec 31, 2025 428.45 Mn
Sep 30, 2025 437.77 Mn
Jun 30, 2025 433.75 Mn
Mar 31, 2025 375.44 Mn
Dec 31, 2024 368.22 Mn
Sep 30, 2024 366.39 Mn
Dec 31, 2023 499.85 Mn
Jun 30, 2023 531.51 Mn
Dec 31, 2022 344.54 Mn
Sep 30, 2022 343.62 Mn
Mar 31, 2022 381.17 Mn
Dec 31, 2021 371.24 Mn
Sep 30, 2021 299.28 Mn
Dec 31, 2020 248.54 Mn
Sep 30, 2010 35.83 Mn
Jun 30, 2010 32.22 Mn
Mar 31, 2010 32,965.79
Dec 31, 2009 39.05 Mn